Stefan V. Goldberg - Publications

Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials.

Journal: The Journal of infectious diseases

Published: March 09, 2025

Reasons for acceptance or nonparticipation in iAdhere: a trial of latent TB infection treatment.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: October 29, 2024

A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.

Journal: American journal of respiratory and critical care medicine

Published: February 15, 2023

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

Journal: The New England journal of medicine

Published: May 05, 2021

Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experience.

Journal: Contemporary clinical trials

Published: January 20, 2021

Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.

Journal: Clinical trials (London, England)

Published: November 07, 2019

High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.

Journal: Contemporary clinical trials

Published: October 28, 2019

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.

Journal: MMWR. Morbidity and mortality weekly report

Published: June 29, 2018

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.

Journal: Annals of the American Thoracic Society

Published: February 03, 2018

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Journal: The Lancet. Respiratory medicine

Published: January 16, 2018

Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: January 15, 2017

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.

Journal: Journal of clinical microbiology

Published: June 23, 2016